President / CEO John Miller Intends to Purchase 500,000 Shares in THC BioMed Intl Ltd.
VANCOUVER, May 22, 2019 /PRNewswire/ - THC BioMed Intl Ltd. (THC.CN), ("THC" or the "Company") announces that John Miller, President, Chief Executive Officer and director of the Company, plans to purchase up to 500,000 additional common shares (the "Shares") in the capital of the Company. The purchases will occur over a three week period ending on June 7, 2019.
Mr. Miller is purchasing the Shares for investment purposes, and commented, "I am very satisfied with the progress THC BioMed has made to become a profitable company." He currently holds 25,318,071 of the 146,379,363 issued and outstanding common shares in the capital of the Company representing 17.3%.
About THC
THC is an ACMPR Licensed Producer and Canada's largest supplier of legal Cannabis Genetics. THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry. Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
